Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of FavId™ (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06

NCT00104819 is registered in ClinicalTrials.gov with Favrille as lead sponsor.

NCT NCT00104819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of FavId™ (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06
Lead sponsor
Favrille
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2004
Completion date
Not reported
Enrollment
238 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma